Health care is more than treatment—it’s time to get serious about disease prevention

COVID dealt Canada’s multiple sclerosis community a major blow—it’s time to close the gap

A new report reveals nearly $600-million in additional costs from the pandemic health-care system disruption through a blend of delayed MS diagnosis, and delayed or foregone treatment.

A cure for multiple sclerosis could be just around the corner

We owe it to Canada to seize this moment and fund research on ‘Canada’s disease’ with renewed vigour and purpose.

COVID-19 has opened the door for conversations about health-care reform, but are we willing to listen?